Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
21.17
-0.30 (-1.40%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $742.94 million as of June 15, 2026. Its market cap has increased by 963.68% in one year.
Market Cap
742.94M
Enterprise Value
502.39M
1-Year Change
963.68%
Ranking
Category
Stock Price
$21.17
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $742.94M, an increase of 40.52%. That is a compound annual growth rate of 15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 742.94M | 34.35% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 803.73M |
| Kura Oncology | 803.41M |
| Odyssey Therapeutics | 797.24M |
| Vor Biopharma | 778.11M |
| Avalo Therapeutics | 775.87M |
| Annexon | 771.70M |
| Zevra Therapeutics | 747.81M |
| Geron | 737.75M |